Oncopharmpod
Encorafenib & Binimetinib
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:17:41
- Mas informaciones
Informações:
Sinopsis
The newly FDA-approved BRAF & MEK inhibitors are discussed, along with their possible clinical relevance and some notable differences compared to previously available BRAF & MEK inhibitors.
